| Typicality: | 0.341 |
| Saliency: | 0.214 |
| for treatment of anaphylaxis | 3 | purpose |
| epinephrine → be → primary drug | 3 |
| epinephrine → be → first line-medication of choice | 3 |
| negative | neutral | positive |
| 0.073 | 0.766 | 0.161 |
| Raw frequency | 6 |
| Normalized frequency | 0.214 |
| Modifier score | 0.500 |
| Perplexity | 20.148 |